June 3, 2014| Premia Spine, formerly known as Impliant, announced this week that it was able to raise $7 million of its $10 million financing goal for the development of its artificial lumbar plates for the spine. According to Globes, the company, which is active in the UK, Germany, Austria, Italy and Israel, has already made NIS 5-8 million in sales after only two years on the market. Although not currently available in the United States, Premia Spine hopes to use recent investments to seal American marketing approval and begin sales there.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Startup Tests Cancer Treatment With Pharma Giant
February 07, 2023

EU Awards $5M To Greenhouse Solar Panel Project
February 07, 2023

Israel Builds Super-Advanced Children’s Hospital
February 07, 2023

Two Thirds Of Hi-Tech Workers In Israel Are Men, Study Finds
February 06, 2023
Facebook comments